Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Marpai ( (MRAI) ) just unveiled an announcement.
On January 16, 2026, Marpai, Inc. announced that President Dallas Scrip resigned, effective January 30, 2026, with the company stating his departure did not stem from any disagreement over operations, policies or practices. On January 23, 2026, the board appointed current Chief Executive Officer and director Damien Lamendola as President, also effective January 30, 2026, consolidating top leadership roles under an executive with a long track record in healthcare benefits and related investments who has previously engaged in disclosed securities purchase agreements with Marpai and whose additional relationships with the company have been characterized as limited to those prior transactions and his existing compensation arrangements, signaling a continuity-focused leadership transition with acknowledged related-party ties already on the record for investors and other stakeholders.
The most recent analyst rating on (MRAI) stock is a Sell with a $0.55 price target. To see the full list of analyst forecasts on Marpai stock, see the MRAI Stock Forecast page.
Spark’s Take on MRAI Stock
According to Spark, TipRanks’ AI Analyst, MRAI is a Neutral.
The score is held down primarily by weak financial performance (shrinking revenue, ongoing losses, negative free cash flow, and negative equity). Technicals add pressure with a clear downtrend and weak momentum. The earnings call provides some offset from cost reductions and new funding, but the large revenue decline and limited cash keep overall risk elevated.
To see Spark’s full report on MRAI stock, click here.
More about Marpai
Marpai, Inc. operates in the health benefits and insurance-related services space, with a focus on administering and managing employer-sponsored health plans using data-driven and technology-enabled solutions. The company’s leadership includes executives with extensive backgrounds in health benefits administration, pharmacy benefit management, and related healthcare investment entities, underscoring its positioning within the broader healthcare services and benefits management sector.
Average Trading Volume: 23,524
Technical Sentiment Signal: Sell
Current Market Cap: $13.41M
For detailed information about MRAI stock, go to TipRanks’ Stock Analysis page.